185 related articles for article (PubMed ID: 15279214)
1. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
Stoutjesdijk JA; Alsma J; Wildschut HI
Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214
[TBL] [Abstract][Full Text] [Related]
2. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
Verhulsdonk MT; Papatsonis DN; Heydanus R
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
[TBL] [Abstract][Full Text] [Related]
3. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
Willems FE
Ned Tijdschr Geneeskd; 2004 Aug; 148(33):1656-7; author reply 1657. PubMed ID: 15455517
[No Abstract] [Full Text] [Related]
4. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
Ebbers S; Creemers JW; Lotgering FK
Ned Tijdschr Geneeskd; 2009; 153():A138. PubMed ID: 19930731
[TBL] [Abstract][Full Text] [Related]
5. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
Jansen NE; Pasker-De Jong PC; Zondervan HA
J Matern Fetal Neonatal Med; 2008 Nov; 21(11):847-51. PubMed ID: 18979392
[TBL] [Abstract][Full Text] [Related]
7. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
Hagar DL; Valley MT; Rayburn WF; Carey JC
J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
[TBL] [Abstract][Full Text] [Related]
8. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
Goh SE; Thong KJ
Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
[TBL] [Abstract][Full Text] [Related]
9. [Induced termination of second and third trimester pregnancy in women with scarred uterus].
Zou LY; Fan L
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920
[TBL] [Abstract][Full Text] [Related]
10. [Premature termination of pregnancy in the 2nd and 3rd trimester. Serial administration of 1 mg gemeprost vaginal suppositories versus intravenous sulproston].
Müller T; Backe J; Rempen A
Geburtshilfe Frauenheilkd; 1996 May; 56(5):234-8. PubMed ID: 8768060
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol for second trimester pregnancy termination in women with prior caesarean section.
Daskalakis GJ; Mesogitis SA; Papantoniou NE; Moulopoulos GG; Papapanagiotou AA; Antsaklis AJ
BJOG; 2005 Jan; 112(1):97-9. PubMed ID: 15663405
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
Herabutya Y; Chanrachakul B; Punyavachira P
BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
[TBL] [Abstract][Full Text] [Related]
14. One or two day mifepristone-misoprostol interval for second trimester abortion.
Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
17. Second-trimester pregnancy termination: comparison of three different methods.
Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
Tang OS; Lau WN; Chan CC; Ho PC
BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
[TBL] [Abstract][Full Text] [Related]
19. Success rate of second-trimester termination of pregnancy using misoprostol.
Prachasilpchai N; Russameecharoen K; Borriboonhirunsarn D
J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
[TBL] [Abstract][Full Text] [Related]
20. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
